Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Dara S Ross"'
Autor:
Chiu-Hsiang Connie Liao, Nilay Bakoglu, Emine Cesmecioglu, Matthew Hanna, Fresia Pareja, Hannah Y. Wen, Timothy M. D’Alfonso, Edi Brogi, Yukako Yagi, Dara S. Ross
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Human epidermal growth factor receptor 2 (HER2) gene amplification and subsequent protein overexpression is a strong prognostic and predictive biomarker in invasive breast carcinoma (IBC). ASCO/CAP recommended tests for HER2 assessment include immuno
Externí odkaz:
https://doaj.org/article/5ad66b7fe96047f1846f4c6e6e954da9
Autor:
Yao-Tseng Chen, Dara S Ross, Rita Chiu, Xi K Zhou, Yunn-Yi Chen, Peishan Lee, Syed A Hoda, Andrew J Simpson, Lloyd J Old, Otavia Caballero, A Munro Neville
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17876 (2011)
BACKGROUND: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer pati
Externí odkaz:
https://doaj.org/article/34ea04b1abef49289b26983128c04d1f
Autor:
Nelson S. Moss, Jolene M. Singh, Anne S. Reiner, Joshua Z. Drago, Shanu Modi, Andrew D. Seidman, Sarat Chandarlapaty, Dara S. Ross
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-4 (2023)
Abstract The HER2-directed antibody-drug conjugate trastuzumab deruxtecan is active against lower levels of HER2 expression than prior-generation therapies. The rate of HER2 expression in brain metastases among patients with initially HER2-null breas
Externí odkaz:
https://doaj.org/article/363af6000ded4e01a37cf337a8a93041
Publikováno v:
Applied Microscopy, Vol 53, Iss 1, Pp 1-16 (2023)
Abstract In the evaluation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) — one of the standard biomarkers for breast cancer— visual assessment is laborious and subjective. Image analysis using whole slide image (WS
Externí odkaz:
https://doaj.org/article/b8e57c0b392c456591526933604a6ce0
Autor:
A. Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu, Fanli Meng, Mohammad Haque, Justyna Sadowska, Brian J. Murphy, Tessara Baldi, Ian Johnson, Ryan Ptashkin, Maysun Hasan, Preethi Srinivasan, Anoop Balakrishnan Rema, Ivelise Rijo, Aaron Agarunov, Helen Won, Dilmi Perera, David N. Brown, Aliaksandra Samoila, Xiaohong Jing, Erika Gedvilaite, Julie L. Yang, Dennis P. Stephens, Jenna-Marie Dix, Nicole DeGroat, Khedoudja Nafa, Aijazuddin Syed, Alan Li, Emily S. Lebow, Anita S. Bowman, Donna C. Ferguson, Ying Liu, Douglas A. Mata, Rohit Sharma, Soo-Ryum Yang, Tejus Bale, Jamal K. Benhamida, Jason C. Chang, Snjezana Dogan, Meera R. Hameed, Jaclyn F. Hechtman, Christine Moung, Dara S. Ross, Efsevia Vakiani, Chad M. Vanderbilt, JinJuan Yao, Pedram Razavi, Lillian M. Smyth, Sarat Chandarlapaty, Gopa Iyer, Wassim Abida, James J. Harding, Benjamin Krantz, Eileen O’Reilly, Helena A. Yu, Bob T. Li, Charles M. Rudin, Luis Diaz, David B. Solit, Maria E. Arcila, Marc Ladanyi, Brian Loomis, Dana Tsui, Michael F. Berger, Ahmet Zehir, Ryma Benayed
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Liquid biopsies allow the non-invasive detection of somatic mutations from tumours. Here, the authors develop and test MSK-ACCESS, an NGS-based clinical assay for identifying low frequency mutations in 129 genes and describe how it benefits patients
Externí odkaz:
https://doaj.org/article/ca7c61a9651341a5819f1ee6a4c47bfa
Autor:
Edaise M. da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M. Gazzo, Higinio Dopeso, Dara S. Ross, Ariya Bakhteri, Nadeem Riaz, Sarat Chandarlapaty, Pedram Razavi, Larry Norton, Hannah Y. Wen, Edi Brogi, Britta Weigelt, Hong Zhang, Jorge S. Reis-Filho
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Metaplastic breast cancers (MBCs) are characterized by complex genomes, which seem to vary according to their histologic subtype. TERT promoter hotspot mutations and gene amplification are rare in common forms of breast cancer, but present i
Externí odkaz:
https://doaj.org/article/f132c81e88b1476593e2db603427ca32
Autor:
Molly P. Hogan, Joao V. Horvat, Dara S. Ross, Varadan Sevilimedu, Maxine S. Jochelson, Laurie J. Kirstein, Shari B. Goldfarb, Christopher E. Comstock, Janice S. Sung
Publikováno v:
Breast Cancer Research and Treatment. 198:349-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf5db8207b63d4f44518991e4da0e60e
https://doi.org/10.1007/s10549-023-06865-8
https://doi.org/10.1007/s10549-023-06865-8
Autor:
Donna C. Ferguson, Amir Momeni Boroujeni, Tao Zheng, Abhinita S. Mohanty, Alan L. Ho, Maria E. Arcila, Dara S. Ross, Snjezana Dogan
Publikováno v:
Modern Pathology. 35:895-902
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98d9a0e4c802a3af88cea240fb1c4844
https://doi.org/10.1038/s41379-021-00999-0
https://doi.org/10.1038/s41379-021-00999-0
Autor:
Dara S. Ross, Timothy M. D’Alfonso
Publikováno v:
Surgical Pathology Clinics. 15:133-146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cedfa4e3a966b6730de969380344357
https://doi.org/10.1016/j.path.2021.11.009
https://doi.org/10.1016/j.path.2021.11.009
Autor:
Kerry Mullaney, Donna C. Ferguson, Tiffany A. Traina, Marc Ladanyi, Timothy Ky. Tay, Ryma Benayed, Edi Brogi, Maria E. Arcila, Douglas A. Mata, Sarat Chandarlapaty, Ayca Gucalp, Timothy M. D'Alfonso, Dara S. Ross
Publikováno v:
Modern Pathology. 35:396-402
Androgen receptor (AR) inhibitor therapy is a developing treatment for AR-positive breast cancer (BC) with ongoing clinical trials. AR splice variant-7 (AR-V7) is a truncated variant of AR that leads to AR inhibitor therapy resistance in prostate can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c868a70e90fa921de935fb2c86906aa3
https://doi.org/10.1038/s41379-021-00924-5
https://doi.org/10.1038/s41379-021-00924-5